Research

Cancer’s Common Ground

The launch of the nation’s first-ever cancer database will help doctors and researchers share information and learn from one another


By Shanley Pierce | August 3, 2016

Vice President Joe Biden took the stage in June at the American Society of Clinical Oncology’s annual conference in Chicago to announce the unveiling of the nation’s first-ever open-access cancer database.

Besides being a massive hub of storage, the Genomic Data Commons (GDC) offers a platform for doctors and researchers to analyze and share genomic and clinical data from a large pool of patients.

“What’s special and different about the GDC is we’re opening up all the software tools and analysis tools to any researcher, any hospital, whoever wants to contribute genomic data from patients with cancer and clinical data,” said Louis M. Staudt, M.D., Ph.D., director of the National Cancer Institute’s Center for Cancer Genomics, who oversaw the development of the database. “In time, the idea would be the explanatory power of the data: The GDC would grow and we would be able to identify subtypes of cancer that have interesting genetic abnormalities that might suggest treatment.”

As part of the National Cancer Moonshot—an initiative led by Biden to end cancer—the GDC gathers information from various programs supported by the National Cancer Institute, including The Cancer Genome Atlas; Therapeutically Applicable Research to Generate Effective Treatments (TARGET), a group that studies molecular changes that drive childhood cancers; and Foundation Medicine, Inc., a molecular information company that generates genomic profiles of cancer patients.

Researchers can contribute data to the GDC with a six-month period of exclusivity, during which time they are able to compare their patients’ data to the rest of the information in the database, Staudt said. After that, they are required to make their information available to qualified researchers, who submit research proposals to access the information.

“There’s a nice opportunity here to begin to standardize across entities and efforts that will hopefully allow us to do the more broad-sweeping and more confident comparisons across institutions and tumor types,” said Andrew Futreal, Ph.D., professor of genomics at The University of Texas MD Anderson Cancer Center. “I think that, from a TMC perspective, if there’s a common pipeline that is available, particularly for cancer analysis … then we have the opportunity to avail both small and large operations of more common architectures and infrastructures because the code they’ll use and the pipeline they can use through the GDC can be replicated in places where they have the horsepower to do it.”

As co-leader of MD Anderson’s Moon Shots Program, Futreal has helped develop platforms for genomics and Big Data, including the Translational Research Accelerator. Similar to the GDC, the accelerator contains approximately 250,000 active MD Anderson patients and 20,000 sets of genomic, immune profiling and protein data.

MD Anderson President Ronald DePinho, M.D., said he appreciates a database with a breadth of information, rather than a “baseball card worth of clinical stats.”

“The national GDC is a strong step in the right direction,” DePinho said. “While it is currently focused on genomic data, it should strive to also integrate proteomics, metabolomics and the immune-profiling data. It is the integration of these data that will provide us with a comprehensive view of cancer’s molecular complexity in the context of clinical care, enabling us to understand the disease on a most elemental level and to learn from different cancers.”

By outlining common molecular defects in various cancer patients, doctors would potentially be able to develop more targeted therapies and identify which clinical trials would be best suited for their patients with the goal of finding “the right drug for the right patient at the right time,” Staudt said.

Ultimately, the GDC is a testament to the medical community’s continued efforts to foster a culture of collaboration that will not only benefit patients today, but will “drive new standards of care for tomorrow,” DePinho said.

“It’s one for all and all for one,” DePinho said. “At the end of the day, the most important thing is for us to advance the field for the benefit of humanity. We have to put the patient before all else. We have to put the problem and progress as the highest priorities that transcend any individual or any institution.”




Social Posts

profile_image

Veterans Affairs

@DeptVetAffairs

Tractor Supply honors 50 veterans nationwide https://t.co/qMGdUHz707 via @DailyTimes

14 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Veterans use art to help others during their recovery https://t.co/vcMbVOHCEY via @NY1

2 hours ago
profile_image

BCMHouston

@bcmhouston

Managing an overactive bladder can be difficult while traveling for summer vacation. Dr. Alexander Pastuszak shares some tips on what you can do to travel more comfortably. https://t.co/0vIlkV3nlV #overactivebladder #traveltips

3 hours ago
profile_image

UTHealth

@UTHealth

In observance of Men’s Health Month, the experts at UTHealth and @UTPhysicians the clinical practice of @McGovernMed, have identified five things men need to know to keep their health in check: https://t.co/i7EIgZOhWM

3 hours ago
profile_image

Texas Children's

@TexasChildrens

Camp For All 2U brings summer camp to Texas Children's Hospital! Patients are invited to go canoeing, participate in archery and make new friends. Learn more from @HoustonChron : https://t.co/k1slUCnqAn

4 hours ago
profile_image

Memorial Hermann

@memorialhermann

Let’s talk about the Big Four. And we’re not referencing the number of major American pro sports leagues, gentlemen. Read more: https://t.co/INqCdH6RTT. #menshealthmonth https://t.co/iPcveD89NP

4 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Q&A: @SecWilkie on VA Mission Act https://t.co/lEsiraS6o4 via @wvpublic

4 hours ago
profile_image

TAMU Health Sciences

@TAMHSC

Today we opened our brand new research facility! The Medical Research and Education Building II doubles the existing research space for the Health Science Center on the Bryan campus. Whoop! 👍Learn more about the MREB II → https://t.co/DtcNt2hlLY https://t.co/slDVZDeXXF

5 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Our @DavidHongMD explains how tisotumab vedotin works in treating #cervicalcancer: https://t.co/xebLn7m3cI @OncLive #gynsm #endcancer

5 hours ago
profile_image

University of Houston

@UHouston

RT @UHOnlineCoogs: The B.A and B.S in Psychology is offered online. These completion degrees are for students who have some college credit…

5 hours ago
profile_image

CHI St. Luke's Health

@CHI_StLukes

RT @KHOU: Get well soon, Mack! https://t.co/WDk43ZutWp

5 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Want to donate goods or services to MD Anderson to support our patients? Learn about what items can be donated: https://t.co/5HsnmWmxdt #endcancer

5 hours ago
profile_image

University of Houston

@UHouston

RT @UHadmissions: Another week means another #TributeTuesday! Christine Ha, @theblindcook won the @MASTERCHEFonFOX competition, and is also…

6 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

@vigilcd @JLo We're thinking of you, Camille. Let us know if you need anything while you're here.

6 hours ago
profile_image

Houston Methodist

@MethodistHosp

RT @Daily_Experts: Congratulations to Dr. Tetsuo Ashizawa of Houston Methodist Hospital -- Recognized as an Expertscape World Expert in Ata…

6 hours ago